NCT06790225View on ClinicalTrials.gov

Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)

NANot yet recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

April 1, 2026

Study Completion Date

April 30, 2027

Conditions
Bone Disease, MetabolicDiabetes Mellitus, Type 2Obesity and Obesity-related Medical Conditions
Interventions
OTHER

Glucose-dependent Insulinotropic Polypeptide (GIP)

Recombinant human GIP (1-42)

Trial Locations (1)

6700

University hospital of Southern Denmark, Esbjerg

All Listed Sponsors
lead

Esbjerg Hospital - University Hospital of Southern Denmark

OTHER